Diabetes Distress?

Distress comes with the territory. The antidote? Small achievable goals. Insights in this podcast.

Recent Content

2014 was the year of the SGLT2 inhibitors in diabetes management.

Diabetes distress -- from an inability to achieve one's A1c goal -- comes with the territory. Quit fighting it, says this diabetes expert, and address it with small achievable goals. Insights in this podcast.

The decision to start insulin therapy requires frank dialogue with a patient about lifestyle, psychosocial, and employment matters. Given this patient's particulars, what type of insulin would you prescribe and on what schedule?

The patient is a 53-year-old African American with type 2 diabetes, in the clinic for regular follow-up. Review the rest of his exam results and select your option for the next step(s).

A new study sheds light on the economic and clinical costs associated with "maintaining a failing T2DM treatment regimen."

Some risk factors for diabetic nephropathy can't be modified, but they support aggressive treatment to control hyperglycemia.

The investigational LX4211 may one day fill a need for these patients who are unable to eliminate a lot of glucose in urine and who respond poorly to selective SGLT2 inhibitors.

By clicking Accept, you agree to become a member of the UBM Medica Community.